跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAR-RANITIDINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MAR-RANITIDINE
Authorized
STANDARD
MAR-RANITIDINE
marcan pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ba0d1f6cf6f03497
Company
marcan pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
ba0d1f6cf6f03497
Drug Approval Canada Name
MAR-RANITIDINE
Product Name
MAR-RANITIDINE
Status
Marketed
Status Date
2018-11-09
Original Market Date
2018-11-09
Din
02443708
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:28.12
Atc Original
A02BA02 RANITIDINE
Atc Name
a 02 ba 02
Aig Number
0115150002
Company Name
marcan pharmaceuticals inc
Company Address
2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2
Active Ingredients
RANITIDINE (RANITIDINE HYDROCHLORIDE)
150 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ba0d1f6cf6f03497
Type
Standard
Back to Health Canada Approvals